Generated by AI
Fortress Biotech, Inc. is a biopharmaceutical company focused on developing, manufacturing, and commercializing pharmaceutical and biotechnology products. Fortress Biotech operates through two core areas: dermatology product sales and pharmaceutical and biotechnology product development. Its commercial portfolio includes prescription and specialty dermatology therapies used for conditions such as acne, rosacea, hyperhidrosis, and other skin-related disorders, alongside wound-care and supportive treatment products. The company also advances a broader pipeline and portfolio of assets through its subsidiary and partner network, supporting programs in areas such as rare diseases and oncology. Fortress Biotech plays a role in the healthcare market by combining product sales with asset development, royalties, and other collaboration-based revenue streams. Headquartered in Bay Harbor Islands, Florida, Fortress Biotech serves a range of medical professionals and patients across the United States and international markets.
Website1111 Kane Concourse
Bay Harbor Islands, FL, 33154
United States
The latest articles about FBIO.
Summary of Nov 13's posts. Generated by AI.
Summary of Feb 23's posts. Generated by AI.
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 28th Annual Global Investment Conference. The prese
Summary of Feb 23's posts. Generated by AI.
Investors talking about FBIO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.